23 Apr, 09:34 - Indian

Nifty Pharma 21506.2 (0.32)

Nifty IT 35087.85 (3.38)

SENSEX 80127.77 (0.67)

Nifty Bank 55761.95 (0.21)

Nifty Next 50 65868.15 (0.49)

Nifty Smallcap 100 17017.75 (0.72)

Nifty 50 24319.1 (0.63)

Nifty Midcap 100 54838.9 (0.81)

23 Apr, 09:34 - Global

NIKKEI 225 34956.65 (2.15)

HANG SENG 22081.42 (2.41)

S&P 5410.5 (1.57)

LOGIN HERE

companylogoPrevest Denpro Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 543363 | NSE Symbol : | ISIN : INE0GAO01018 | Industry : Healthcare |


Chairman's Speech

Dear Stakeholders and Shareholders,

"To be successful in business, you must be willing to explore new ideas and invest in research. Innovation is the driving force behind progress."

Michael Dell

I am pleased to present the annual report for Prevest Denpro Limited for the financial year 2023-2024. It has been a year of commendable achievements and notable challenges, and I am proud to share our progress and performance with you. We are delighted to report a significant revenue increase of 14.27%, from ?51.89 crores in FY 2022-2023 to ?59.29 crores in FY 2023-2024. This growth is particularly impressive given the adverse conditions in foreign markets, where we faced currency exchange crises and a recessionary environment in EU countries due to the ongoing conflict between Russia and Ukraine. Despite these challenges, our domestic market demonstrated robust growth, surpassing last year's performance. Our current utilization of the existing product line stands at 45%, indicating that we have 55% unutilized capacity. This unused capacity positions us well to meet rising market demands and scale up production as needed. The establishment of the Prevest Research Centre in 2023 marks a pivotal step in our journey towards innovation and excellence. This centre is dedicated to advancing our technology and methods to improve efficiency, quality, and sustainability across various industries. Our key initiatives include cost-saving measures, the introduction of new production lines, and the reduction of imports through import substitution. We continue to invest heavily in R&D to develop innovative products. Our collaboration with dental institutions ensures that our product development is aligned with the latest market needs and technological advancements. Oradox has received an overwhelmingly positive response from our stakeholders. This encouraging feedback reaffirms our confidence that Oradox will significantly contribute to our top line in the forthcoming periods. In late 2023, we launched our e-commerce platform, Prevest Direct, which has received a positive response from our customers. Leveraging the success of Prevest Direct, we aim to further expand our online presence and sales channels, driving growth through this strategic initiative. The digital marketplace is a vital component of our strategy to reach a broader audience and provide customers with seamless access to our products. Our focus on digital transformation is not just about technology but also about creating value for our customers and stakeholders. Prevest Denpro Limited is confidently projecting a promising future, driven by the anticipated growth of our diversified product line. Through continuous innovation and strategic market adaptation, we aim to further expand our presence and market share. We will focus on exploring avenues for inorganic growth, including strategic alliances and acquisitions, to enhance our market presence and drive expansion. Our strategic goals are aligned with our mission to provide high-quality, innovative products that meet the evolving needs of our customers. We believe that by fostering a culture of innovation and excellence, we can achieve sustainable growth and long-term success. In conclusion, I would like to extend my heartfelt gratitude to our shareholders, customers, employees, and partners for their unwavering support and confidence in Prevest Denpro Limited. Your trust and loyalty have been instrumental in our success, and we are committed to delivering even greater value in the years to come. Together, we will continue to strive for excellence and achieve greater heights in the coming years.

Atul Modi

Chairman & Managing Director

   

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +